New gene therapy tackles tough pancreatic cancer
Disease control
Recruiting now
This early-stage trial tests a new cell-based gene therapy called RR001 given after chemotherapy for people with locally advanced pancreatic cancer that cannot be removed by surgery. The study aims to check safety and find the best dose in a small group of 9 participants. It is n…
Phase: PHASE1, PHASE2 • Sponsor: EIR Biotherapies s.r.l. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC